BR9301420A - Muteina de fator de necrose,sequencia de dna,vetor,celula hospedeira,composto,processo para sua preparacao,composicao farmaceutica e uso - Google Patents

Muteina de fator de necrose,sequencia de dna,vetor,celula hospedeira,composto,processo para sua preparacao,composicao farmaceutica e uso

Info

Publication number
BR9301420A
BR9301420A BR9301420A BR9301420A BR9301420A BR 9301420 A BR9301420 A BR 9301420A BR 9301420 A BR9301420 A BR 9301420A BR 9301420 A BR9301420 A BR 9301420A BR 9301420 A BR9301420 A BR 9301420A
Authority
BR
Brazil
Prior art keywords
vector
compound
preparation
pharmaceutical composition
host cell
Prior art date
Application number
BR9301420A
Other languages
English (en)
Portuguese (pt)
Inventor
Werner Lesslauer
Hansruedi Loetscher
Dietrich Stueber
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR9301420A publication Critical patent/BR9301420A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BR9301420A 1992-04-02 1993-04-02 Muteina de fator de necrose,sequencia de dna,vetor,celula hospedeira,composto,processo para sua preparacao,composicao farmaceutica e uso BR9301420A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92810249 1992-04-02

Publications (1)

Publication Number Publication Date
BR9301420A true BR9301420A (pt) 1993-10-05

Family

ID=8211902

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9301420A BR9301420A (pt) 1992-04-02 1993-04-02 Muteina de fator de necrose,sequencia de dna,vetor,celula hospedeira,composto,processo para sua preparacao,composicao farmaceutica e uso

Country Status (19)

Country Link
US (1) US5486463A (enrdf_load_html_response)
EP (1) EP0563714A3 (enrdf_load_html_response)
JP (1) JPH07285997A (enrdf_load_html_response)
CN (1) CN1037844C (enrdf_load_html_response)
AU (1) AU659927B2 (enrdf_load_html_response)
BR (1) BR9301420A (enrdf_load_html_response)
CA (1) CA2091313A1 (enrdf_load_html_response)
CZ (1) CZ283533B6 (enrdf_load_html_response)
FI (1) FI931488A7 (enrdf_load_html_response)
HU (1) HUT69790A (enrdf_load_html_response)
IL (1) IL105170A0 (enrdf_load_html_response)
MX (1) MX9301700A (enrdf_load_html_response)
NO (1) NO931141L (enrdf_load_html_response)
NZ (1) NZ247265A (enrdf_load_html_response)
PL (1) PL298345A1 (enrdf_load_html_response)
SK (1) SK376492A3 (enrdf_load_html_response)
TW (1) TW260707B (enrdf_load_html_response)
UY (1) UY23561A1 (enrdf_load_html_response)
ZA (1) ZA932177B (enrdf_load_html_response)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970005042B1 (ko) * 1993-02-09 1997-04-11 한일합성섬유공업 주식회사 종양괴사인자-알파 뮤테인
CA2119089A1 (en) * 1993-03-29 1994-09-30 David Banner Tumor necrosis factor muteins
CN1049663C (zh) * 1994-09-01 2000-02-23 中国科学院上海生物工程研究中心 突变的人肿瘤坏死因子
US7070771B1 (en) 1996-12-09 2006-07-04 Regents Of The University Of California Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders
US6379708B1 (en) * 1999-11-20 2002-04-30 Cytologic, Llc Method for enhancing immune responses in mammals
DK1666052T3 (da) * 2000-02-16 2011-09-12 Genentech Inc Anti-APRIL monoklonalt antistof og dets anvendelse til behandling af en immum-relateret sygdom eller cancer
EA200601861A1 (ru) * 2001-08-03 2007-02-27 Дженентек, Инк. ПОЛИПЕПТИДЫ TACIs И BR3 И ИХ ПРИМЕНЕНИЕ
US7786282B2 (en) * 2001-12-06 2010-08-31 The Regents Of The University Of California Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domain
US20030199024A1 (en) * 2002-04-19 2003-10-23 Hansen Ted H. Single chain trimers of class I MHC molecules
JP2005533863A (ja) * 2002-07-25 2005-11-10 ジェネンテック・インコーポレーテッド Ｔａｃｉ抗体とその用途
JP4754219B2 (ja) * 2002-12-02 2011-08-24 アムジエン・フレモント・インコーポレイテツド 腫瘍壊死因子を対象とする抗体、およびそれらの使用
US20040121971A1 (en) * 2002-12-20 2004-06-24 Gang Chen Therapeutic use of tumor necrosis factor-alpha mutein
US20050163775A1 (en) * 2003-06-05 2005-07-28 Genentech, Inc. Combination therapy for B cell disorders
CA2526402A1 (en) * 2003-06-05 2005-01-20 Genentech, Inc. Blys antagonists and uses thereof
CN100390200C (zh) * 2003-11-24 2008-05-28 中国医学科学院基础医学研究所 一种用于治疗获得性免疫缺陷综合征的重组靶向融合蛋白
TW200526780A (en) 2004-01-06 2005-08-16 Hayashibara Biochem Lab TNF antagonists and TNF inhibitors comprising the same as the active ingredient
CN1752211B (zh) * 2004-09-23 2010-09-15 中国医学科学院基础医学研究所 用于治疗获得性免疫缺陷综合征的重组靶向融合蛋白
GB0425972D0 (en) 2004-11-25 2004-12-29 Celltech R&D Ltd Biological products
US7850960B2 (en) 2004-12-30 2010-12-14 University Of Washington Methods for regulation of stem cells
US20070065514A1 (en) * 2005-09-22 2007-03-22 Howell Mark D Method for enhancing immune responses in mammals
US9726673B2 (en) * 2005-11-23 2017-08-08 Genentech, Inc. Methods and compositions related to B cell assays
US8518697B2 (en) * 2006-04-04 2013-08-27 Washington University Single chain trimers and uses therefor
WO2008019394A2 (en) * 2006-08-11 2008-02-14 The Government Of The United States Of America As Represented By The Secretary, Dept Of Health And Human Services Methods for treatment and diagnosis of psychiatric disorders
WO2008127515A1 (en) * 2007-03-01 2008-10-23 Cytologic, Inc. Compositions and method for enhancing immune responses in mammals
HRP20211353T1 (hr) 2013-02-07 2021-11-26 The General Hospital Corporation Postupci za ekspanziju ili depleciju regulacijskih t-stanica
US11224858B1 (en) 2020-10-01 2022-01-18 Immunicom, Inc. Reduced leaching of a ligand
CA3194403A1 (en) 2020-10-01 2022-04-07 Steven Josephs Reduced leaching of a ligand
WO2025163107A1 (en) 2024-02-01 2025-08-07 Institut Gustave Roussy Immune cells defective for znf217 and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07106158B2 (ja) * 1986-12-04 1995-11-15 サントリー株式会社 抗腫瘍活性を有する新規ポリペプチドおよびその製造法
CA2055168A1 (en) * 1990-11-21 1992-05-22 Walter Fiers Tnf-muteins

Also Published As

Publication number Publication date
MX9301700A (es) 1993-10-29
HU9300843D0 (en) 1993-06-28
CA2091313A1 (en) 1993-10-03
FI931488A0 (fi) 1993-04-01
FI931488L (fi) 1993-10-03
IL105170A0 (en) 1993-07-08
ZA932177B (en) 1993-10-04
CN1079225A (zh) 1993-12-08
JPH07285997A (ja) 1995-10-31
EP0563714A2 (en) 1993-10-06
CN1037844C (zh) 1998-03-25
NO931141L (no) 1993-10-04
US5486463A (en) 1996-01-23
TW260707B (enrdf_load_html_response) 1995-10-21
UY23561A1 (es) 1993-09-20
AU659927B2 (en) 1995-06-01
FI931488A7 (fi) 1993-10-03
AU3561193A (en) 1993-10-07
CZ283533B6 (cs) 1998-04-15
CZ376492A3 (en) 1994-01-19
NZ247265A (en) 1995-10-26
NO931141D0 (no) 1993-03-26
PL298345A1 (en) 1993-12-27
SK376492A3 (en) 1995-06-07
HUT69790A (en) 1995-09-28
EP0563714A3 (en) 1993-11-10

Similar Documents

Publication Publication Date Title
BR9301420A (pt) Muteina de fator de necrose,sequencia de dna,vetor,celula hospedeira,composto,processo para sua preparacao,composicao farmaceutica e uso
BR9401321A (pt) Muteína, sequência de DNA, vetor, célula, sequência de RNA composto, processo para sua preparação, composição farmacêutica e uso.
BR9200951A (pt) Compostos, processo para sua producao,preparacoes farmaceuticas e uso
BR9301137A (pt) Composto,formulacao farmaceutica,sulfonamida e processo para sua preparacao
ITRM940621A0 (it) "composizione farmaceutica stabilizzata, relativo solvente e procedimento di preparazione"
BR8906988A (pt) Tetrapiptidio,peptidio,composicao farmaceutica,processo para uso de peptidio e reagente para diagnostico
FI943687L (fi) Uudet 11-bentsaldoksiimiestradieenijohdannaiset, menetelmät niiden valmistamiseksi ja näitä yhdisteitä sisältävät lääkeaineet
BR9807814B1 (pt) composto de pirazina, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto.
FI954329A0 (fi) Farmaseuttisina aineina käytettäviä nukleiinihappoja
FI955913A7 (fi) Uudet erytromysiinijohdannaiset, menetelmät niiden valmistamiseksi ja niiden käyttö lääkkeinä
BR9501770A (pt) Uso de um composto,composto,formulação farmacêutica e processo para preparar um composto
BR9810829B1 (pt) composto heterocìclico, processo para preparar o mesmo, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica.
BR9801606B1 (pt) composto, processo para sua preparação, substáncia farmacêutica, uso do composto e processo para a produção de uma substáncia farmacêutica.
BR9808422B1 (pt) composto, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto.
DK394489A (da) I para-stillingen heterocyclisk substituerede n-phenylamidforbindelser, mellemprodukter ved deres fremstilling, farmaceutiske praeparater indeholdende forbindelserne og anvendelse af forbindelserne til fremstilling af antiarytmiske laegemidler
BR9600147A (pt) Purin-6-onas 2,9-DI-substituidas processo para sua preparação medicamentos e uso
BR9712058B1 (pt) formulações para uso de ivermectina, processo para sua preparação e uso.
FI951726A0 (fi) Boronihappopeptidijohdannaisia, niiden valmistus ja käyttö synteesivälituotteina
BR9503876A (pt) Quinoxalina-2,3-diona-oxa-ou tec-alifaticamente ligada em ponte processo para sua preparação compostos uso dos mesmos e composições farmacêuticas
BR9507473A (pt) Sequéncia de dna isolada vetor célula hospedeira processo para produzir uma proteina gp350 homogénea proteína gp350 homogénea composição farmacéutica e uso na proteina gp350 homogénea
BR9106744A (pt) Processo para induzir diferenciacao celular,preparacao farmaceutica,composicao e uso de um composto
AR002978A1 (es) Compuestos benzamidas, composiciones farmacéuticasque los contienen, metodos para preparar los mismos y el uso de los mismos.
BR9302359A (pt) Composto,processo para sua preparacao,medicamento e uso
DK558283D0 (da) Spiro-3-heteroazolidindion-forbindelser og farmaceutisk acceptable salte deraf,farmaceutisk praeparat indeholdende saadanne forbindelser og mellemprodukter ved deres fremstilling
BR9600779A (pt) Benzenossulfoniluréias e -tioréias substituidas processo para sua preparação uso e medicamento

Legal Events

Date Code Title Description
EE Request for examination
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
B15K Others concerning applications: alteration of classification

Ipc: C07K 14/525 (2006.01), A61K 38/00 (2006.0